ERBB2 and invasive ductal breast carcinoma: Also, MDM2 overexpression in MCF-7 (estrogen receptor positive, Her2-negative) and MDA-MB-231 (triple-negative) cell lines promotes invasion and metastasis in invasive ductal breast carcinoma by upregulating matrix metalloproteinase-9 [38].